Assignee
ORIGENE TECHNOLOGIES INC
US·9 granted patents·3 pending applications·102 citations·filing 1999–2003
Top patents by PatentIndex Score
12 records- 0185US6455292B1Full-length serine protein kinase in brain and pancreasORIGENE TECHNOLOGIES INC·Filed 2001·Granted Sep 24, 2002·23 cites·6 claims
- 0284US6316193B1Rapid-screen cDNA library panelsORIGENE TECHNOLOGIES INC·Filed 1999·Granted Nov 13, 2001·57 cites·22 claims
- 0381US7115393B2Melanocortin-1 receptor and methods of useORIGENE TECHNOLOGIES INC·Filed 2002·Granted Oct 3, 2006·10 cites·14 claims
- 0477US6657054B1Regulated angiogenesis genes and polypeptidesORIGENE TECHNOLOGIES INC·Filed 2002·Granted Dec 2, 2003·4 cites·3 claims
- 0573US6833247B2Regulated prostate cancer genesORIGENE TECHNOLOGIES INC·Filed 2002·Granted Dec 21, 2004·5 cites·14 claims
- 0668US6780595B2Human Tbx20 gene and usesORIGENE TECHNOLOGIES INC·Filed 2002·Granted Aug 24, 2004·1 cites·11 claims
- 0768US6635481B1Tbx3 gene and methods of using itORIGENE TECHNOLOGIES INC·Filed 2001·Granted Oct 21, 2003·1 cites·5 claims
- 0853US7053193B2Breast cancer transcription factor gene and usesORIGENE TECHNOLOGIES INC·Filed 2002·Granted May 30, 2006·1 cites·15 claims
- 0943US6953673B2Histamine H2 receptor and usesORIGENE TECHNOLOGIES INC·Filed 2001·Granted Oct 11, 2005·0 cites·14 claims
- 1043US2002031779A1Rapid-screen cDNA library panelsORIGENE TECHNOLOGIES INC·Filed 2001·Application pending·0 cites
- 1139US2005120393A1Full-length prostate selective polynucleotides and polypeptidesORIGENE TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 1239US2006026700A1Tissue specific genes and gene clustersORIGENE TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →